Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Vivos Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 28 | 28 | 0 |
| Shares | 2.49M | 2.18M | −304.8K (−12.3%) |
| Value | $6.66M | $2.82M | −$3.84M (−57.7%) |
New holders (5)
Institutions that held Vivos Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 11,805 | $15.0K | 0.00% |
| Ronald Blue Trust, Inc. | 4,000 | $11.0K | 0.00% |
| UBS Group AG | 2,213 | $3.00K | 0.00% |
| Wagner Wealth Management, LLC | 2,000 | $3.00K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (5)
Institutions that held Vivos Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 170,264 | $456.0K |
| Griffin Asset Management, Inc. | 70,200 | $188.0K |
| Susquehanna International Group, LLP | 23,740 | $64.0K |
| Millennium Management LLC | 11,244 | $30.0K |
| IFP Advisors, Inc | 150 | $1.00K |